Introduction:
Chronic bronchitis is a condition affecting the respiratory tract. It falls under the category of COPD. COPD is a term that comprises diseases that are seen to affect the respiratory tract. Due to this infection, people frequently experience weight loss, low energy, dry mouth, chronic cough, and more. Mucus is a sticky substance that acts as a first line of defense for the various epithelia inside the body against various harmful pathogens. Its work also entails the protection of the epithelium from the excoriating irritants found in the gastrointestinal tract.
People with chronic bronchitis experience recurrent exacerbations with an increase in volume, the purulence of sputum, or both. Mucolytics are seen to reduce the exacerbations slightly in patients with chronic bronchitis or COPD. However, these might have little or no effect on the overall quality of life. Mucokinetic medications like bronchodilators help in the clearance of cough from the airways.
What Is Chronic Bronchitis?
Chronic bronchitis falls under the category of chronic obstructive pulmonary disease (COPD), defined as a productive cough of more than three months occurring within two years. Patients of chronic bronchitis typically complain of chronic productive cough, malaise, and symptoms of excessive coughing like chest or abdominal pain. Chronic bronchitis irritates the bronchial tubes; these tubes transport air to and from the lungs. As a result of this, the tubes become swollen, and mucus begins accumulating alongside the lining of the lungs. This accumulation leads to the narrowing of the tube's opening, making it hard to receive air into and out of the lungs.
What Are Mucolytics?
Mucolytics are the drugs that break up mucus so that it can be cleared out of the lungs in an easier manner. They are used to treat problems like cystic fibrosis (a genetically acquired condition in which severe damage to the lungs, digestive system, and other organs in the body is caused), bronchiectasis (a condition in which airways widen or develop pouches and too much coughing occurs with a lot of mucus and frequent infections), and other lung conditions. They are present in three forms- oral, intravenous (IV), and nebulizer.
Mucolytics fall under the category of a more general group of medications termed as mucoactive agents. Mucoactive agents have several ways of eliminating mucus from the lungs. They might break up mucus, turn it thin, or allow it to move more easily from the lungs. Other mucoactive agents are expectorants, mu-coregulators, and mucokinetics.
What Are Mucokinetics?
A microkinetic drug increases mucociliary clearance, frequently by acting on the cilia. Although a variety of medications, such as tricyclic nucleotides, -agonist bronchodilators, and methylxanthine bronchodilators, all increase ciliary beat frequency. These agents have only a minimal effect on mucociliary clearance in patients with lung disease.
Most of these agents are also mucus secretagogues that may paradoxically increase the burden of airway secretions. Bronchodilator medications can also increase airway collapse in patients with bronchomalacia because they relax airway smooth muscle.
What Do Mucolytics and Mucoactive Agents Do?
The body has its protective covering and a tendency to eliminate dust or bacteria from the body. These accumulate in the form of mucus. Production of mucus has various purposes, even when a person is healthy. Also, mucus keeps the tissues of the lungs, throat, etc, healthy and prevents them from drying. Excessive mucus is secreted in case of severe respiratory diseases like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. Airway mucosal infection or inflammation linked with such diseases frequently results in inflammatory products like neutrophil-derived DNA and filamentous actin. Bacteria, apoptotic cells, and cellular debris might also altogether elevate mucus formation and viscosity. Mucoactive agents are regarded as the choice of medication for the treatment of respiratory illness in which mucus hypersecretion is a primary clinical issue.
When the lungs function normally, mucus traps the irritants and infectious particles (like bacteria or viruses). Hairlike structures present in the lungs (cilia) assist in clearing out the mucus, and all the things get trapped in it while coughing. However, in certain chronic lung conditions, a large amount of thick, hard-to-clear mucus is formed. This can make it difficult for a person to breathe and trap germs in their lungs, resulting in causing sickness more easily.
Mucolytics help in breaking apart the molecules that form the mucus, turning it thinner and easier to clear out from the lungs. Mucokinetics works by increasing the potential to expectorate sputum or decrease mucus hypersecretion.
What Are Mucolytic and Mucokinetic Therapies for Chronic Bronchitis?
Mucolytic Drugs: Certain mucolytic drugs are seen to manage chronic bronchitis. Some of these are:
-
N-Acetyl Cysteine (NAC): It is an idly incorporated mucolytic agent used in various respiratory diseases like COPD, chronic bronchitis, and more. It is seen to not only exert mucolytic properties but also antioxidant effects, which might act as a guard against free radical damage. It also reduces airway inflammation by reducing lysozyme and lactoferrin concentrations in people who smoke. Some pieces of evidence also suggest that oral NAC might also decrease exacerbation rates in cases of chronic bronchitis.
-
Carbocysteine: Carbocysteine increases the volume of sputum, thus producing an additional expectorative effect. It is safe and effective for asthmatics, and it does not harm the respiratory tract.
Mucokinetics:
A large of mucokinetic agents (sometimes termed cough clearance promoters) promote mucociliary clearance by acting on the cilia. However, many mucokinetics that increase ciliary beat frequency are available, but these agents only have some effect on mucociliary clearance in patients dealing with pulmonary disease. Examples of mucokinetic medications are bronchodilators, tricyclic nucleotides, and Ambroxol.
Conclusion:
A mucus is a sticky substance secreted in response to any foreign particle. The hypersecretion of mucus is a clinical feature of various respiratory diseases like asthma, chronic bronchitis, cystic fibrosis, and chronic obstructive pulmonary disease. Mucoactive agents are suggested in these cases. Mucolytic and mucokinetic drugs are the types of mucoactive drugs. People with chronic bronchitis experience recurrent exacerbations with an increase in volume, the purulence of sputum, or both. Mucolytics are seen to reduce the exacerbations slightly in patients with chronic bronchitis or COPD. Meanwhile, mucokinetics help ease the clearance of the cough.
